采用环磷酰胺、六甲蜜胺、阿霉素和顺二氯二氨铂联合方案（CHAP）治疗化疗耐药的晚期卵巢癌。 - Suppr | 超能文献

Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP).

作者信息

Bruckner H W, Cohen C J, Deppe G, Kabakow B, Wallach R, Ratner L, Holland J F

出版信息

Gynecol Oncol. 1981 Oct;12(2 Pt 1):150-3. doi: 10.1016/0090-8258(81)90144-x.

DOI:10.1016/0090-8258(81)90144-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP).采用环磷酰胺、六甲蜜胺、阿霉素和顺二氯二氨铂联合方案（CHAP）治疗化疗耐药的晚期卵巢癌。

Gynecol Oncol. 1981 Oct;12(2 Pt 1):150-3. doi: 10.1016/0090-8258(81)90144-x.

2

Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.

Cancer Treat Rep. 1981 Jan-Feb;65(1-2):149-51.

3

Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.

Cancer Treat Rep. 1979 Feb;63(2):307-9.

4

Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.

Cancer Treat Rep. 1982 May;66(5):1233-4.

5

Alternating multiagent chemotherapy for advanced ovarian cancer.晚期卵巢癌的交替多药化疗。

J Surg Oncol. 1983 Feb;22(2):87-91. doi: 10.1002/jso.2930220206.

6

Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer.

Am J Obstet Gynecol. 1983 Mar 15;145(6):653-8. doi: 10.1016/0002-9378(83)90569-0.

7

Combination chemotherapy for advanced ovarian cancer: a prospective randomized trial comparing hexamethylmelamine and cyclophosphamide to doxorubicin and cyclophosphamide.

Cancer Treat Rep. 1981 Jan-Feb;65(1-2):137-41.

8

Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.六甲蜜胺、阿霉素、环磷酰胺（HAC）与顺铂、阿霉素、环磷酰胺（PAC）治疗晚期卵巢癌的随机对照比较：长期结果

Cancer Treat Rev. 1991 Mar;18 Suppl A:37-46. doi: 10.1016/0305-7372(91)90023-s.

9

Treatment of ovarian cancer with a combination of cis-platinum, adriamycin, cyclophosphamide and hexamethylmelamine.

Oncology. 1982;39(4):205-8. doi: 10.1159/000225638.

10

Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.用于卵巢癌的六药联合化疗（六甲蜜胺、阿霉素、顺铂、环磷酰胺、甲氨蝶呤和5-氟尿嘧啶；CHAMP-5）：联合方案的交替序列

Cancer Treat Rep. 1985 Jun;69(6):689-93.

引用本文的文献

1

Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.六甲蜜胺。对其药效学和药代动力学特性以及在癌症化疗中的治疗潜力的综述。

Drugs. 1995 Jun;49(6):932-53. doi: 10.2165/00003495-199549060-00007.